EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Ke, Xia ^a   Yang, Yu Cheng ^a   Hong, Su Ling ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Deoxyribozymes (DNAzymes); Epstein Barr virus (EBV); Growth; Latent membrane protein1 (LMP1); Nasopharyngeal carcinoma (NPC)

Indexed keywords

ANTINEOPLASTIC AGENT; DZ 509; LATENT MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; DOWN REGULATION; DRUG SYNTHESIS; DRUG TARGETING; EPSTEIN BARR VIRUS; GENE TARGETING; HUMAN; HUMAN CELL; MALE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

EID: 84655161327     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9681-2     Document Type: Article

References (39)

1. A Mutirangura 1997 Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection Br J Cancer. 76 770 776 (Pubitemid 27379745)
2. AT Chan PM Teo PJ Johnson 2002 Nasopharyngeal carcinoma Ann Oncol. 13 1007 1015
3. JP Spano 2003 Nasopharyngeal carcinomas: an update Eur J Cancer. 39 2121 2135
4. XP Li G Li Y Peng HF Kung MC Lin 2004 Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells Biochem Biophys Res Commun. 315 212 218 (Pubitemid 38175207)
5. AW Lee 1992 Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure Int J Radiat Oncol Biol Phys. 23 261 270
6. WY Wang 2010 Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma Clin Cancer Res. 16 1016 1024
7. E Seto T Ooka J Middeldorp K Takada 2008 Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity Cancer Res. 68 1030 1036 (Pubitemid 351272220)
8. JH Lu 2010 Epstein-Barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance Lab Invest. 90 196 209
9. X Lin 2009 EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells Int J Cancer. 124 1020 1027
10. R Jiang G Cabras W Sheng Y Zeng T Ooka 2009 Synergism of BARF1 with Ras induces malignant transformation in primary primate epithelial cells and human nasopharyngeal epithelial cells Neoplasia. 11 964 973
11. N Sivachandran F Sarkari L Frappier 2008 Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies PLoS Pathog. 4 e1000170
12. T Yoshizaki 2001 Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma Clin Cancer Res. 7 1946 1951 (Pubitemid 32994829)
13. S Murono 2001 Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells Proc Natl Acad Sci USA. 98 6905 6910 (Pubitemid 32538315)
14. S Kondo 2006 EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1 alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells Cancer Res. 66 9870 9877 (Pubitemid 44672038)
15. T Horikawa 2001 Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma Am J Pathol. 159 27 33 (Pubitemid 33704188)
16. H Zheng LL Li DS Hu XY Deng Y Cao 2007 Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma Cell Mol Immunol. 4 185 196
17. YP Mei 2007 Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells Cell Cycle. 6 1379 1385
18. CR Dass PF Choong LM Khachigian 2008 DNAzyme technology and cancer therapy: cleave and let die Mol Cancer Ther. 7 243 251 (Pubitemid 351302518)
19. Y Isaka 2007 DNAzymes as potential therapeutic molecules Curr Opin Mol Ther. 9 132 136 (Pubitemid 46623945)
20. SH Yu TH Wang LC Au 2009 Specific repression of mutant K-RAS by 10-23 DNAzyme: sensitizing cancer cell to anti-cancer therapies Biochem Biophys Res Commun. 378 230 234
21. Z Liang 2005 DNAzyme-mediated cleavage of survivin mRNA and inhibition of the growth of PANC-1 cells J Gastroenterol Hepatol. 20 1595 1602 (Pubitemid 43961117)
22. C Liu R Cheng LQ Sun P Tien 2001 Suppression of platelet-type 12-lipoxygenase activity in human erythroleukemia cells by an RNA-cleaving DNAzyme Biochem Biophys Res Commun. 284 1077 1082 (Pubitemid 32924758)
23. ZX Lu 2008 DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma Cancer Lett. 265 226 238
24. ZX Lu 2005 Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis Cancer Gene Ther. 12 647 654
25. H Liu 2009 LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells Mol Cancer. 8 92
26. A Abdelgany MK Uddin M Wood K Taira D Beeson 2005 Design of efficient DNAzymes against muscle AChR alpha-subunit cRNA in vitro and in HEK 293 cells J RNAi Gene Silencing. 1 88 96
27. B Sriram AC Banerjea 2000 In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression Biochem J. 352 Pt 3 667 673 (Pubitemid 32015021)
28. I Guasparri D Bubman EEBV Cesarman 2008 LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression Blood. 111 3813 3820
29. L Deng 2003 Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1 Cell Res. 13 187 194
30. YP Mei XF Zhu JM Zhou H Huang R Deng YX Zeng 2006 siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression Cancer Lett. 232 189 198 (Pubitemid 43170968)
31. C Du 2006 Downregulation of Epstein-Barr virus-encoded latent membrane protein-1 by arsenic trioxide in nasopharyngeal carcinoma cells Tumori. 92 140 148 (Pubitemid 43835974)
32. CH Ho CL Chen WY Li CJ Chen 2009 Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion Carcinogenesis. 30 1443 1451
33. L Li 2007 Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases Cancer Lett. 255 219 231 (Pubitemid 47271954)
34. L Terrin 2008 Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes J Virol. 82 10175 10187
35. KR Kim 2000 Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth Oncogene. 19 1764 1771
36. X Yang 2000 LMP1 of Epstein-Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatively transforms the cells with a p16-insensitive CDK4 oncogene J Virol. 74 883 891 (Pubitemid 30036225)
37. L Yang 2009 Effect of DNAzymes targeting Akt1 on cell proliferation and apoptosis in nasopharyngeal carcinoma Cancer Biol Ther. 8 366 371
38. BE Barton TF Murphy P Shu HF Huang M Meyenhofer A Barton 2004 Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines Mol Cancer Ther. 3 1183 1191 (Pubitemid 39440162)
39. A Mitchell CR Dass LQ Sun LM Khachigian 2004 Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1 Nucleic Acids Res. 32 3065 3069 (Pubitemid 39022997)